Comments
Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration to manufacture and market Esomeprazole Magnesium delayed release capsules.
The approved abbreviated new drug application (ANDA) is bio equivalent and therapeutically equivalent to the reference listed drug product Nexium delayed release capsules of AstraZeneca Pharmaceuticals. It is indicated in treatment of gastroesophageal reflux disease.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.